Healio Dermatology announces new Peer Perspective Board
Click Here to Manage Email Alerts
Key takeaways:
- Healio Dermatology has a new Peer Perspective Board.
- Board members are esteemed experts in the dermatology field and will help guide coverage.
Thorofare, NJ – Healio Dermatology is excited to announce the establishment of a new Peer Perspective Board. The board members, consisting of key opinion leaders and experts in dermatology, will assist in content selection and act as ambassadors for Healio beginning Feb. 7, 2024.
The Peer Perspective Board is led by Chief Medical Editor, Joel M. Gelfand, MD, MSCE. Gelfand formerly served as Chief Medical Editor for Healio Psoriatic Disease and is the James J. Leyden Professor of Clinical Investigation and professor of dermatology and epidemiology at University of Pennsylvania’s Perelman School of Medicine, the founding scientific director of the Center for Clinical Sciences in Dermatology, as well as the medical director of the Psoriasis and Phototherapy Treatment Center. In his new expanded role for Healio Dermatology, he will help inform coverage and contribute video and written commentary to the site.
“I am delighted to work with Healio Dermatology and the outstanding experts on the Peer Perspective Board to help provide our colleagues who take care of dermatology patients with the most timely new information they need to achieve great clinical outcomes,” Gelfand said. “Together we will help identify the most promising new developments in the field of dermatology which is seeing unprecedented advances in the medical, surgical and cosmetic management of skin disorders.”
Joining Healio Dermatology are:
Macrene Alexiades, MD, PhD, FAAD
Alexiades is an Associate Clinical Professor in Dermatology at Yale University School of Medicine and dual US-EU board-certified, internationally recognized practicing dermatologist and scientist who specializes in laser surgery and injectables at the Dermatology and Laser Surgery Center of New York.
Jerry Bagel, MD, MS
Bagel is director of the Psoriasis Treatment Center of Central New Jersey and clinical professor of dermatology at Icahn School of Medicine at Mount Sinai. He specializes in treating psoriasis, for which he is nationally recognized, and atopic dermatitis.
Tina Bhutani, MD, MAS
Bhutani is co-director of the Psoriasis and Skin Treatment Center and director of the dermatology clinical research unit at University of California, San Francisco. She specializes in the treatment of inflammatory skin conditions including psoriasis and atopic dermatitis.
Dawn Marie R. Davis, MD
Davis is professor of dermatology and pediatrics, consultant in the departments of dermatology and pediatric and adolescent medicine, and chair of the division of clinical dermatology at the Mayo Clinic.
Lawrence Eichenfield, MD
Eichenfield is chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego, distinguished professor of dermatology and pediatrics, vice chair of the department of dermatology at University of California, San Diego and directs the UCSD/Rady Eczema and Inflammatory Skin Disease and Rare Skin Disease Centers.
Anthony Fernandez, MD, PhD
Fernandez is a dermatologist and dermopathologist whose practice and research focuses on complex medical dermatology. He is a clinical assistant professor of medicine at Cleveland Clinic’s Lerner College of Medicine, Director of medical dermatology and the W.D. Steck Chair of Clinical Dermatology at the Cleveland Clinic.
Adam Friedman, MD, FAAD
Friedman is professor and chair of dermatology and serves as residency program director, director of translational research, and director of the supportive oncodermatology program in the department of dermatology at George Washington University School of Medicine & Health Sciences.
Emma Guttman-Yassky, MD, PhD
Guttman-Yassky is the Waldman Professor of Dermatology and Immunology and health system chair of the department of dermatology at Icahn School of Medicine at Mount Sinai. She is the director of the Occupational Dermatitis Clinic and director of the Laboratory for Inflammatory Skin Diseases.
John E. Harris, MD, PhD
Harris is the founding director of the Vitiligo Clinic and Research Center, founding director of the Autoimmune Therapeutics Institute and professor and chair of the department of dermatology at UMass Chan Medical School.
Jennifer L. Hsiao, MD
Hsiao is associate professor of dermatology at Keck School of Medicine at the University of Southern California, where she also serves as director of the Hidradenitis Suppurativa Specialty Clinic.
Brett King, MD, PhD
King is associate professor of dermatology at Yale University School of Medicine. He pioneered the use of Janus kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, atopic dermatitis, granulomatous diseases, and other conditions.
Ginette A. Okoye, MD
Okoye is professor and chair of dermatology at Howard University College of Medicine. She specializes in cutaneous disorders — such as hidradenitis suppurativa, cutaneous T-cell lymphoma and alopecia — that disproportionately affect people with skin of color.
Veronica Richardson, MSN, ANP-BC
Richardson is a dermatology nurse practitioner at University of Pennsylvania Perelman Center for Advanced Medicine Psoriasis Treatment Center.
Hannah Rodriguez, MPAS, PA-C
Rodriguez is a dermatology physician assistant at Pennsylvania Dermatology Group. She currently serves as president of the Pennsylvania Dermatology Physician Assistants.